Page last updated: 2024-09-05

sorafenib and Dermatitis Exfoliativa

sorafenib has been researched along with Dermatitis Exfoliativa in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borrás-Blasco, J; Casterá, ME; Galán Brotons, A; Rosique-Robles, JD; Vicent Verge, JM	1

Reviews

1 review(s) available for sorafenib and Dermatitis Exfoliativa

Article	Year
Sorafenib (Nexavar) for thyroid cancer. The Medical letter on drugs and therapeutics, 2014, May-26, Volume: 56, Issue:1443 Topics: Animals; Antineoplastic Agents; Dermatitis, Exfoliative; Humans; Niacinamide; Phenylurea Compounds; Randomized Controlled Trials as Topic; Sorafenib; Thyroid Neoplasms	2014

Other Studies

1 other study(ies) available for sorafenib and Dermatitis Exfoliativa

Article	Year
Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:12 Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Dermatitis, Exfoliative; Drug Eruptions; Female; Humans; Kidney Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Skin; Sorafenib; Treatment Outcome	2008

Article

Year

Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:12

Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Dermatitis, Exfoliative; Drug Eruptions; Female; Humans; Kidney Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Skin; Sorafenib; Treatment Outcome

2008